PRESS RELEASE published on 07/20/2023 at 07:00, 2 years 8 months ago Biophytis a requis auprès de la FDA une réunion de pré-soumission d’Autorisation d’Utilisation d’Urgence de Sarconeos (BIO101) dans le traitement du COVID-19
PRESS RELEASE published on 07/19/2023 at 07:53, 2 years 8 months ago Biophytis annonce un Placement Direct Enregistré de 3,8 millions de dollars
PRESS RELEASE published on 07/19/2023 at 07:53, 2 years 8 months ago Biophytis Announces $3.8 Million Registered Direct Offering
PRESS RELEASE published on 07/18/2023 at 07:00, 2 years 8 months ago Biophytis et SEQENS signent un partenariat pour la production du principe actif de Sarconeos (BIO101)
PRESS RELEASE published on 07/18/2023 at 07:00, 2 years 8 months ago Biophytis and SEQENS sign a partnership to produce Sarconeos (BIO101) active compound
PRESS RELEASE published on 07/10/2023 at 07:00, 2 years 8 months ago Biophytis has filed with the FDA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 07/10/2023 at 07:00, 2 years 8 months ago Biophytis a demandé à la FDA l’autorisation de lancer l’étude SARA-31 de phase 3 dans la sarcopénie
PRESS RELEASE published on 06/19/2023 at 07:00, 2 years 9 months ago Biophytis présente les résultats cliniques de Sarconeos (BIO101) dans la sarcopénie au 16ème congrès international SCWD
PRESS RELEASE published on 06/19/2023 at 07:00, 2 years 9 months ago Biophytis reports clinical results for Sarconeos (BIO101) in sarcopenia treatment at the 16th SCWD International Congress
PRESS RELEASE published on 06/16/2023 at 23:00, 2 years 9 months ago Biophytis: RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED
Published on 03/23/2026 at 21:18, 19 minutes ago Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 7 hours 32 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 7 hours 37 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 8 hours 32 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 9 hours 5 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 21:05, 32 minutes ago Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 32 minutes ago Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 36 minutes ago Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 41 minutes ago Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable
Published on 03/23/2026 at 19:08, 2 hours 29 minutes ago Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 2 hours 29 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 2 hours 59 minutes ago ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 3 hours 52 minutes ago ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 3 hours 52 minutes ago En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde
